Wednesday, October 20, 2021

The FDA authorizes Moderna and J&J COVID vaccine boosters
FDA panel unanimously recommends Moderna Covid booster shots for at-risk adults
An FDA panel of experts backs J&J COVID vaccine booster
FDA advisers endorse Moderna booster shot: Three takeaways
Risk of dangerous blood clots linked to moderate COVID-19; high-dose blood thinner can prevent clots
U.S. moves closer to clearing Moderna and J&J Covid booster shots this week
Moderna, Racing for Profits, Keeps COVID Vaccine Out of Reach of Poor
FDA analysis of J&J COVID vaccine booster sets the stage for public hearing
A study of COVID vaccine boosters suggests Moderna or Pfizer works best
Merck asks FDA to authorize promising anti-COVID pill
New antiviral is highly effective, study finds, and is stirring hope that COVID-19 could be treated by a pill
Merck says experimental COVID-19 pill cut deaths, hospitalizations in half when given early
FDA won't extend shelf life of J&J Covid vaccine doses, may extend life of millions of Moderna shots
New study reveals how many lives the COVID-19 vaccine really saved
General public should wait to get a booster shot: Doctor
A F.D.A. panel will discuss shots for children 5 to 11 and boosters for adults.
FDA advisers to review COVID-19 shots for young kids, boosters this month
Pfizer/BioNTech COVID-19 vaccine effectiveness drops after 6 months, study shows
J&J is asking the FDA to authorize its COVID-19 booster shots
For People Who Got The J&J Vaccine, Some Doctors Are Advising Boosters ASAP
Covid-19 live updates: Third coronavirus shot side effects echo those from second dose, CDC says
CDC panel endorses Pfizer Covid booster shots for high-risk adults, rejects plan to distribute widely across America
CDC Director Backs COVID Booster Plan And Makes An Additional Recommendation
Moderna vs. Pfizer: Both Knockouts, but One Seems to Have the Edge
An FDA Panel Says Only High-Risk Americans And Those 65+ Should Get COVID Boosters
An F.D.A. panel recommends Pfizer boosters for those over 65 or at high risk of severe Covid.
Johnson & Johnson Says Its Booster Shot Provides Increased Protection From COVID-19
An extra J. & J. shot substantially boosts protection against Covid, the company reports.
The FDA Has Been Without A Permanent Leader For 8 Months As COVID Cases Climb
CDC study finds Moderna vaccine is best at preventing Covid-19 hospitalization
F.D.A. Vaccine Panel Meeting on Pfizer Booster Shots
Pediatric group warns coronavirus cases in kids are rising 'exponentially'
Pfizer Analysis Makes The Case For A COVID Booster Shot. The FDA's Stance Is Expected Today
A Pfizer Analysis Makes The Case For A COVID Vaccine Booster
An Epidemiologist Says At-Home Testing Is Key To Stopping COVID
FDA Experts Are Among A Group That Opposes The U.S. Booster Shot Plan
For millions, COVID-19 won’t quit. Doctors strive for answers on how to ease long-hauler misery.
The Death Of A 12-Year-Old Boy Sparks Worries Of A Nipah Virus Outbreak In India
Why The World Should Be More Than A Bit Worried About India's Nipah Virus Outbreak
What is the Nipah virus and why is it more deadly than COVID-19? A virus expert explains.
New studies find evidence of ‘superhuman’ immunity to COVID-19 in some individuals
Sinovac booster shot reverses drop in antibody activities against Delta-study
Moderna Has Asked The FDA To Authorize A Booster Of Its COVID-19 Vaccine

No comments: